LA JOLLA PHARMACEUTICAL CO Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Buy | P | 5.57 | 200 | 1,114 | 5,259 | 5.1 K to 5.3 K (+3.95 %) |
| Jan 31 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Buy | P | 5.57 | 800 | 4,456 | 5,059 | 4.3 K to 5.1 K (+18.78 %) |
| Jan 31 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Buy | P | 5.57 | 1,200 | 6,684 | 4,259 | 3.1 K to 4.3 K (+39.23 %) |
| Jan 31 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Buy | P | 5.55 | 800 | 4,440 | 3,059 | 2.3 K to 3.1 K (+35.41 %) |
| Jan 28 2019 | LJPC | LA JOLLA PHARMACEU ... | Johnson Craig A | Director | Option Exercise | A | 5.99 | 12,000 | 71,880 | 12,000 | |
| Jan 25 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Option Exercise | A | 5.99 | 12,000 | 71,880 | 12,000 | |
| Jan 25 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 5.99 | 53,000 | 317,470 | 53,000 | |
| Jan 25 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 5.99 | 53,000 | 317,470 | 53,000 | |
| Jan 25 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 5.99 | 53,000 | 317,470 | 53,000 | |
| Jan 25 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 5.99 | 53,000 | 317,470 | 53,000 | |
| Jan 25 2019 | LJPC | LA JOLLA PHARMACEU ... | Douglass Laura L. | Director | Option Exercise | A | 5.99 | 12,000 | 71,880 | 12,000 | |
| Jan 25 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 5.99 | 174,000 | 1,042,260 | 174,000 | |
| Jan 25 2019 | LJPC | LA JOLLA PHARMACEU ... | Rosen Robert | Director | Option Exercise | A | 5.99 | 12,000 | 71,880 | 12,000 | |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 6.75 | 213 | 1,438 | 213 | |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 5.74 | 213 | 1,223 | 12,329 | 12.1 K to 12.3 K (+1.76 %) |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.75 | 316 | 2,133 | 316 | |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.74 | 316 | 1,814 | 977 | 661 to 977 (+47.81 %) |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.75 | 72 | 486 | 72 | |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.74 | 72 | 413 | 2,259 | 2.2 K to 2.3 K (+3.29 %) |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.75 | 792 | 5,346 | 792 | |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.74 | 792 | 4,546 | 77,122 | 76.3 K to 77.1 K (+1.04 %) |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 6.75 | 874 | 5,900 | 874 | |
| Jan 17 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 5.74 | 874 | 5,017 | 1,284,200 | 1.3 M to 1.3 M (+0.07 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.26 | 450,235 | 2,368,236 | 2,253,376 | 2.7 M to 2.3 M (-16.65 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.25 | 800,000 | 4,200,000 | 2,703,611 | 3.5 M to 2.7 M (-22.83 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 6.46 | 25,800 | 166,668 | 3,503,611 | 3.5 M to 3.5 M (-0.73 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.26 | 4,200 | 22,092 | 3,529,411 | 3.5 M to 3.5 M (-0.12 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 6.46 | 25,800 | 166,668 | 3,533,611 | 3.6 M to 3.5 M (-0.72 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.26 | 4,200 | 22,092 | 3,559,411 | 3.6 M to 3.6 M (-0.12 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 9.52 | 4,592 | 43,716 | 3,563,611 | 3.6 M to 3.6 M (-0.13 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 9.05 | 34,401 | 311,329 | 3,568,203 | 3.6 M to 3.6 M (-0.95 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 7.56 | 131,866 | 996,907 | 3,602,604 | 3.7 M to 3.6 M (-3.53 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 6.67 | 147,497 | 983,805 | 3,734,470 | 3.9 M to 3.7 M (-3.80 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 5.64 | 431,644 | 2,434,472 | 3,881,967 | 4.3 M to 3.9 M (-10.01 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.54 | 79,214 | 438,806 | 4,938,893 | 4.9 M to 4.9 M (+1.63 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.43 | 120,786 | 655,699 | 4,859,679 | 4.7 M to 4.9 M (+2.55 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.38 | 200,000 | 1,075,700 | 4,738,893 | 4.5 M to 4.7 M (+4.41 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.34 | 200,000 | 1,067,920 | 4,538,893 | 4.3 M to 4.5 M (+4.61 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.24 | 200,000 | 1,047,940 | 4,338,893 | 4.1 M to 4.3 M (+4.83 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.24 | 200,000 | 1,048,980 | 4,138,893 | 3.9 M to 4.1 M (+5.08 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.33 | 200,000 | 1,066,400 | 3,938,893 | 3.7 M to 3.9 M (+5.35 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.84 | 100,000 | 583,840 | 3,738,893 | 3.6 M to 3.7 M (+2.75 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.54 | 79,214 | 438,806 | 4,938,893 | 4.9 M to 4.9 M (+1.63 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.43 | 120,786 | 655,699 | 4,859,679 | 4.7 M to 4.9 M (+2.55 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.38 | 200,000 | 1,075,700 | 4,738,893 | 4.5 M to 4.7 M (+4.41 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.34 | 200,000 | 1,067,920 | 4,538,893 | 4.3 M to 4.5 M (+4.61 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.24 | 200,000 | 1,047,940 | 4,338,893 | 4.1 M to 4.3 M (+4.83 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 436 | 2,551 | 1,283,326 | 1.3 M to 1.3 M (+0.03 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.24 | 200,000 | 1,048,980 | 4,138,893 | 3.9 M to 4.1 M (+5.08 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 700 | 4,095 | 1,282,890 | 1.3 M to 1.3 M (+0.05 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.33 | 200,000 | 1,066,400 | 3,938,893 | 3.7 M to 3.9 M (+5.35 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 397 | 2,322 | 1,282,190 | 1.3 M to 1.3 M (+0.03 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TANG KEVIN C | Director | Buy | P | 5.84 | 100,000 | 583,840 | 3,738,893 | 3.6 M to 3.7 M (+2.75 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 98 | 573 | 1,281,793 | 1.3 M to 1.3 M (+0.01 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 287 | 1,679 | 1,281,695 | 1.3 M to 1.3 M (+0.02 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 82 | 480 | 1,281,408 | 1.3 M to 1.3 M (+0.01 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.17 | 1,000 | 6,167 | 12,116 | 11.1 K to 12.1 K (+9.00 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.16 | 1,000 | 6,157 | 11,116 | 10.1 K to 11.1 K (+9.89 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.15 | 1,000 | 6,149 | 10,116 | 9.1 K to 10.1 K (+10.97 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.17 | 1,000 | 6,166 | 9,116 | 8.1 K to 9.1 K (+12.32 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.19 | 484 | 2,995 | 8,116 | 7.6 K to 8.1 K (+6.34 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.19 | 516 | 3,192 | 7,632 | 7.1 K to 7.6 K (+7.25 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.10 | 800 | 4,880 | 76,330 | 75.5 K to 76.3 K (+1.06 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.09 | 500 | 3,045 | 75,530 | 75 K to 75.5 K (+0.67 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.07 | 300 | 1,821 | 75,030 | 74.7 K to 75 K (+0.40 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 436 | 2,551 | 1,283,326 | 1.3 M to 1.3 M (+0.03 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 700 | 4,095 | 1,282,890 | 1.3 M to 1.3 M (+0.05 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 397 | 2,322 | 1,282,190 | 1.3 M to 1.3 M (+0.03 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 98 | 573 | 1,281,793 | 1.3 M to 1.3 M (+0.01 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 287 | 1,679 | 1,281,695 | 1.3 M to 1.3 M (+0.02 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Buy | P | 5.85 | 82 | 480 | 1,281,408 | 1.3 M to 1.3 M (+0.01 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.17 | 1,000 | 6,167 | 12,116 | 11.1 K to 12.1 K (+9.00 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.16 | 1,000 | 6,157 | 11,116 | 10.1 K to 11.1 K (+9.89 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.15 | 1,000 | 6,149 | 10,116 | 9.1 K to 10.1 K (+10.97 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.17 | 1,000 | 6,166 | 9,116 | 8.1 K to 9.1 K (+12.32 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.19 | 484 | 2,995 | 8,116 | 7.6 K to 8.1 K (+6.34 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Buy | P | 6.19 | 516 | 3,192 | 7,632 | 7.1 K to 7.6 K (+7.25 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.10 | 800 | 4,880 | 76,330 | 75.5 K to 76.3 K (+1.06 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.09 | 500 | 3,045 | 75,530 | 75 K to 75.5 K (+0.67 %) |
| Jan 09 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Buy | P | 6.07 | 300 | 1,821 | 75,030 | 74.7 K to 75 K (+0.40 %) |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 9.43 | 23 | 217 | 23 | |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 8.02 | 23 | 184 | 2,187 | 2.2 K to 2.2 K (+1.06 %) |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 9.43 | 97 | 915 | 97 | |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 8.02 | 97 | 778 | 74,730 | 74.6 K to 74.7 K (+0.13 %) |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 9.43 | 39 | 368 | 39 | |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 8.02 | 39 | 313 | 661 | 622 to 661 (+6.27 %) |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 9.43 | 154 | 1,452 | 154 | |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 8.02 | 154 | 1,234 | 1,281,326 | 1.3 M to 1.3 M (+0.01 %) |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 9.43 | 148 | 1,396 | 148 | |
| Jan 03 2019 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 8.02 | 148 | 1,186 | 7,116 | 7 K to 7.1 K (+2.12 %) |